AIDAN KING

Profile

First Name

: AIDAN

Middle Name

:

Last Name

: KING

Related Companies

Titles

Company Name

Related People

DIRECTOR

PALYON MEDICAL CORP

GREGORY DAVID, GLEN KASHUBA, MICHAEL LIANG, DANIEL OMSTEAD, CHERINE PLUMAKER, DAVID PRESENT

DIRECTOR

CIVITAS THERAPEUTICS, INC.

GLENN BATCHELDER, RICHARD BATYCKY, ANDREA FRANZ, MARTIN FREED, DAVID HIRSCH, ROB HOPFNER, ROBERT HOPFNER, MARK IWICKI, BLAIR JACKSON, TIMOTHY S. NELSON, ROBERT ROCHE, ROBERT P. ROCHE, JR., RAJEEV SHAH, TIM SHANNON, TIMOTHY SHANNON, BRYAN STUART, MARY TAYLOR

DIRECTOR

CHRONO THERAPEUTICS INC.

GUY DIPIERRO, WENDE HUTTON, STEVEN JAMES, TIM KILGALLON, ALAN LEVY, ALAN LEVY, PH.D., ANTHONY RIMAC, ELIZABETH ROCKETT, JAMES W. YOUNG

DIRECTOR

VELICEPT THERAPEUTICS, INC.

JAMES BENNETHUM, CORY S. FREEDLAND, CORY FREEDMAN, DOUG GESSL, DOUGLAS GESSL, DAVID HIRSCH, DAVID HIRSCH, M.D., AIDAN KING, MBA, CFA, JILL BECKER MAST, SCOTT MORENSTEIN, STEPHEN TULLMAN, JAMES WALKER, JAMES C. WALKER

DIRECTOR

XYLOCOR THERAPEUTICS, INC.

FOUAD AZZAM, PH.D., GLENN BATCHELDER, JAMES COHEN, ALBERT GIANCHETTI, MICHAEL F. POWELL, PH.D., TODD ROSENGART, TODD K. ROSENGART, M.D.

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-01-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-07-12

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2016-08-26

D

BIOTECHNOLOGY

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]

DECLINE TO DISCLOSE

Equity

2014-08-22

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-09-03

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-12-27

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2009-04-27

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2009-04-27